` KOPRAN (Kopran Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

KOPRAN
vs
B
BSE Sensex 30

Over the past 12 months, KOPRAN has underperformed BSE Sensex 30, delivering a return of -32% compared to the BSE Sensex 30's +4% growth.

Stocks Performance
KOPRAN vs BSE Sensex 30

Loading
KOPRAN
BSE Sensex 30
Add Stock
www.alphaspread.com

Performance Gap
KOPRAN vs BSE Sensex 30

Performance Gap Between KOPRAN and BSESN
HIDDEN
Show

Performance By Year
KOPRAN vs BSE Sensex 30

Loading
KOPRAN
BSE Sensex 30
Add Stock

Competitors Performance
Kopran Ltd vs Peers

BSE Sensex 30
KOPRAN
LLY
JNJ
NOVO B
ROG
Add Stock

Kopran Ltd
Glance View

Market Cap
8.8B INR
Industry
Pharmaceuticals

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of manufacturing and supplying international formulations (Finished Dosage Form) and active pharmaceutical ingredients (APIs). Its formulation business unit manufactures oral solid dosages and dry powder formulations for both penicillin and non-penicillin-based drugs. Its APIs business unit offers Sterile Cephalosporins and Carbapenems. The company also offers Macrolide, Antibacterial, Anticonvulsant, and Cardiovascular range of drugs. Its product offering includes antibiotics, cardiovascular, antidiabetic, gastrointestinal, pain management, drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, and anthelmintics. Its antibiotics brands include AMPIK 250 / 500, AMPIK SYRUP, and AMYN - 250 / 500. Its cardiovascular brands include CARDIOTEN - 25 / 50 / 100, CADITONE - 3.125 / 6.25 / 12.5 / 25 and KLODIP - 5 / 10.

KOPRAN Intrinsic Value
HIDDEN
Show
Back to Top